Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial

Introduction: Randomized, controlled trials of molnupiravir in real-world use during the Omicron wave are scarce. The frequency of hospitalization and death is low, so further research is needed to confirm the virological efficacy of molnupiravir. Methods: A single-center, randomized, controlled cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yayun, Fan, Shiyong, Xu, Aijing, Ge, Lingling, Wang, Xinyu, Dong, Xu, Xu, Mingxiao, Fan, Wenhan, Zhong, Wu, Liang, Xuesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687146/
https://www.ncbi.nlm.nih.gov/pubmed/38034986
http://dx.doi.org/10.3389/fphar.2023.1197671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687146/
https://www.ncbi.nlm.nih.gov/pubmed/38034986
http://dx.doi.org/10.3389/fphar.2023.1197671

Ejemplares similares